to study how the balance between these two types of daughter cells is maintained. A mutation in teg-4 causes over-proliferation of the stem cells, thereby disrupting the balance between proliferation and differentiation. We have cloned teg-4 and found it to encode a protein homologous to the highly conserved splicing factor subunit 3 of SF3b. Our allele of teg-4 partially reduces TEG-4 function. In an effort to determine how teg-4 functions in controlling stem cell proliferation, we have performed genetic epistasis analysis with known factors controlling stem cell proliferation. We found that teg-4 is synthetic tumorous with genes in both major redundant genetic pathways that function downstream of GLP-1/Notch signaling to control the balance between proliferation and differentiation.
Introduction
A defining characteristic of stem cells is their ability to give rise to both self-renewing daughter cells and differentiating daughter cells. This characteristic allows for a population of stem cells to exist over an extended period of time, providing the source material for developing or renewing tissues. The Caenorhabditis elegans germ line has emerged as an important model to study how the proliferation vs. differentiation decision of dividing stem cells is controlled (Hansen and Schedl, 2006; Kimble and Crittenden, 2007) . In the adult germ line of both hermaphrodite and male C. elegans, different stages of germ cell development are arranged in a linear fashion (Hirsh et al., 1976; Kimble and Hirsh, 1979) most distal from the uterus, referred to as the proliferative zone, contains cells that divide mitotically ( Fig. 1A and B) . At least some of the cells within this zone serve as the stem cell population. As cells progress away from the distal end of the gonad and into the transition zone, they cease proliferating and enter into meiotic prophase. Cells continue to move more proximally, towards the uterus, as they progress through meiotic prophase and eventually complete meiosis and differentiate as either sperm or oocytes.
The cells in the proliferative zone divide mitotically, rather than entering into meiotic prophase, due, in part, to the activity of the GLP-1/Notch signaling pathway (Austin and Kimble, 1987) . The DSL (Delta/Serrate/LAG-2) ligand, LAG-2, is expressed on the somatic distal tip cell (DTC) (Fig. 1A) , which caps the distal end of the gonad (Henderson et al., 1994; Kimble and White, 1981; Tax et al., 1994) . When LAG-2 comes in contact with the GLP-1/Notch receptor, which is expressed on the germ cells, the intracellular portion of GLP-1, INTRA, is thought to be cleaved from the rest of the protein and transported to the nucleus (Mumm and Kopan, 2000) . INTRA is thought to form a complex with the LAG-1 transcription factor and SEL-8/LAG-3 transcriptional co-activator, promoting the transcription of genes necessary for proliferation (Christensen et al., 1996; Doyle et al., 2000; Petcherski and Kimble, 2000) . As cells move away from the distal end of the gonad, GLP-1/Notch signaling levels are thought to decrease, allowing for the activities of two major genetic pathways, which either promote meiotic entry and/or inhibit proliferation, to increase (Fig. 1C ). We will refer to these two pathways as the gld-1 and gld-2 pathways based on the founding genes of each (Francis et al., 1995; Kadyk and Kimble, 1998) . The GLP-1/Notch signaling pathway inhibits the activities of the gld-1 and gld-2 pathways, at least in part, through the FBF-1 and FBF-2 RNA binding proteins, which are homologous to Drosophila Pumilio (Crittenden et al., 2002; Eckmann et al., 2004; Lamont et al., 2004) . The increase in the activities of the gld-1 and gld-2 pathways allows for cells to enter meiotic prophase. The gld-1 and gld-2 pathways function redundantly; if the activity of either pathway is reduced, the transition from proliferation to meiotic entry occurs very similar as in Fig. 1 -The control of proliferation in the C. elegans germ line. (A) Shown is a diagram of a C. elegans adult hermaphrodite emphasizing the two gonad arms. Proliferative cells are found in the region most distal from the uterus of both gonad arms (green). As the cells move proximally, they enter meiotic prophase (red), continuing to progress through meiosis as they move further from the distal end. The first germ cells to differentiate are sperm (blue), followed by oocytes (orange). Oocytes are fertilized as they pass into the uterus, and undergo some mitotic divisions before being expelled into the environment. (B) A dissected gonad arm from an adult hermaphrodite, stained with DAPI to visualize nuclear morphology. Distal is to the left. Proliferative cells move into the transition zone as they switch from a mitotic to a meiotic cell cycle. Scale bar = 20 lm (C) A simplified genetic pathway regulating the proliferation vs. differentiation decision in the C. elegans germ line. glp-1/Notch signaling, including the genes lag-2, glp-1 and lag-1, inhibit the activities of two major downstream pathways, referred to as the gld-1 and gld-2 pathways. glp-1/Notch signaling inhibits these pathways through the activities of other genes not shown, including fbf-1 and fbf-2. The gld-1 and gld-2 pathways inhibit proliferation and/or promote meiotic entry. As cells move away from the distal tip cell (DTC), glp-1/Notch signaling levels are thought to diminish, allowing for the activities of the gld-1 and gld-2 pathways to increase. (D) teg-4(oz210) enhances the size of the proliferative zone in glp-1(ar202gf) animals. The size of the proliferative zone was determined as the number of cell diameters that were anti-REC-8(+) and anti-HIM-3(-) (see Section 4). Error bars are one standard deviation. The size of the proliferative zone in teg-4(oz210); glp-1(ar202gf) animals is significantly larger than in either single mutant (P < 4.3 · 10
À5
, Student's two-tailed t-test, two sample unequal variance).
wild-type (Francis et al., 1995; Kadyk and Kimble, 1998) . However, if the activities of both pathways are reduced, the balance is shifted toward proliferation and a germline tumor results (Eckmann et al., 2004; Hansen et al., 2004a,b; Kadyk and Kimble, 1998) .
Additional genes that function in regulating the proliferation vs. differentiation decision have been identified through enhancer/suppressor screens (Hansen et al., 2004b; MacDonald et al., 2008; Qiao et al., 1995) . Here we describe the genetic and molecular characterization of the teg-4 gene, an allele of which was isolated from a screen for mutations that enhance the germline over-proliferation phenotype of a weak glp-1 gain-of-function allele. We found that teg-4 encodes the C. elegans homologue of the SAP130 splicing factor, which is a subunit of the SF3b splicing complex. The teg-4 allele reduces activity of the protein, and therefore likely reduces splicing efficiency. We propose that the mRNAs of one or more factors that are involved in controlling the proliferation vs. differentiation decision are not spliced properly, thereby reducing their activity and causing cells to over-proliferate.
Results

Isolation of teg-4(oz210) allele
teg-4(oz210) was identified in an EMS mutant screen that will be described in more detail elsewhere. In brief, mutations were isolated that enhanced the germline over-proliferation phenotype of the weak glp-1(oz112gfoz120lf) gain-of-function allele. glp-1(oz112gfoz120lf) animals, which have a low level of germline over-proliferation (Berry et al., 1997) , were mutagenized and F2 progeny were screened for an increase in germline proliferation. Since animals with an over-proliferative, or tumorous, germ line are sterile, the enhancing mutations were isolated from siblings that were heterozygous for the enhancing mutation. From this screen, a single allele of the teg-4 (tumorous enhancer of glp-1(oz112gfoz120lf), oz210, was isolated.
2.2.
teg-4(oz210) enhances over-proliferation of glp-1(ar202gf)
As a first step to understand how the teg-4(oz210) allele affects the proliferation vs. meiotic entry decision, we characterized the ability of teg-4(oz210) to enhance the overproliferation phenotype of a weak glp-1 gain-of-function allele. We analyzed double mutants with the glp-1(ar202gf) allele, which has been used to characterize many other genes affecting the proliferation vs. meiotic entry decision (Fig. 2B ) (Hansen et al., 2004a; MacDonald et al., 2008; Pepper et al., 2003) . We found that germ lines in teg-4(oz210); glp-1(ar202gf) were over-proliferative in both the distal and proximal ends of the gonad. We measured the size of the distal proliferative zone in teg-4(oz210) and glp-1(ar202gf) single mutants and in teg-4(oz210); glp-1(ar202gf) double mutants and found that the size of the proliferative zone in the double mutant was significantly larger than in either single mutant (Fig. 1D) . Additionally, at 15°57% of gonad arms in double mutant animals had ectopic proliferation in the proximal end of the gonad (Pro phenotype, n = 146 arms). No teg-4(oz210) single mutant animals are Pro (n > 100) and only 21% of glp-1(ar202gf) animals are Pro (n = 146 arms) at the same temperature. Therefore, the tumorous phenotype appears to be due to an increase in proliferation, rather than cells returning to the mitotic cell cycle after failing to progress through meiosis.
2.3.
teg-4(oz210) single mutant animals display other phenotypes
In a wild-type background, teg-4(oz210) animals display other developmental and germline phenotypes. At 20°, homozygous teg-4(oz210) animals that are fertile have an average brood size of 195 (n = 10, standard deviation ±86), with 12.9% of the offspring arrested during embryonic development (n = 1952). We analyzed the animals that do reach adulthood and found that 15%, 49% and 67% of these animals are sterile when grown at 15°, 20°or 25°, respectively (n = 703, 2771 and 762, respectively) ( Table 1) . To determine the cause of the sterility we analyzed a portion of these sterile worms by DIC microscopy and observed a number of different phenotypes (Table 2) . We found that a large proportion of the animals appear to make excess sperm at the expense of oogenesis (Mog; masculinization of the germ line), while a smaller percentage have misshapen oocytes, have a small under-proliferative germ line, or have germ cells that appear to be degrading (Table 2). Animals grown at 15°and displaying a Mog phenotype have $288 sperm per gonad arm (288 ± 52, n = 5), whereas wild-type animals only generate $150 sperm per gonad arm (Hirsh et al., 1976) . We also found that teg-4(oz210) fertile animals have a smaller than normal proliferative zone; while wild-type animals have a proliferative zone $20 cell diameters in length (20 ± 2.3, n = 13; Fig. 1D ), the proliferative zone in teg-4(oz210) is only $15 cell diameters long (15 ± 2.3, n = 24; Fig. 1D ).
teg-4(oz210) is likely a partial loss-of-function allele
In order to further characterize the nature of the teg-4(oz210) allele, we placed teg-4(oz210) over deficiencies spanning the region (hDf8 and qDf16) ( Fig. 2C and D) . All teg-4(oz210)/deficiency animals have small under-proliferative germ lines that contain necrotic cells, with very little evidence of differentiated gametes. This under-proliferative phenotype is similar to the strongest phenotype observed in teg-4(oz210) homozygotes, particularly homozygotes grown at 25° (  Table 2 ). Upon molecular identification of teg-4 (see below), we performed RNAi against teg-4. We found that animals exposed to teg-4(RNAi) as L4 animals produced $99% arrested embryos, whereas animals exposed to teg-4(RNAi) as adults produced mostly arrested embryos (85.6%), as well as animals that arrested as larvae (14.1%) ( Table 3 ). Animals that were exposed to teg-4(RNAi) while in the first larval stage, and whose mothers were not exposed to teg-4(RNAi), showed an underproliferative germline phenotype very similar to teg-4(oz210)/ deficiency animals (Fig. 2C, D and F) . The milder phenotype exhibited by teg-4(oz210) homozygotes as compared to teg-4(oz210)/deficiency and teg-4(RNAi) animals suggests that teg-4(oz210) only partially reduces teg-4 function.
2.5.
teg-4 encodes a homologue of a subunit of the SF3b splicing factor complex To determine how teg-4 functions in the regulation of the proliferation vs. differentiation decision we determined its molecular identity. Standard three factor mapping narrowed the location of teg-4(oz210) to the region between dpy-5 and unc-13 on linkage group I. We used SNP (single nucleotide polymorphism) mapping to narrow the region containing teg-4(oz210) (Jakubowski and Kornfeld, 1999) . unc-13 and dpy-5 were used as visible markers to identify animals with a recombination event near teg-4(oz210). We used tumorous enhancement of glp-1(ar202gf) as the visible phenotype for mapping (see Section 4). By identifying recombinants that retained N2 DNA furthest from the corresponding visible marker (dpy-5 or unc-13), we narrowed the critical region containing the oz210 lesion to an $83 kb region containing 18 genes (Fig. 3A) . RNAi clones of 14 of these genes were readily available; therefore, we tested these candidate genes by RNAi to determine if any displayed a similar phenotype to teg-4(oz210) homozygotes or teg-4(oz210)/deficiency hemizygotes. Three genes (K02F2.6/ser-3, K02F2.3/tag-203 and K02F2.2), displayed an under-proliferative germ line phenotype similar to that found in teg-4(oz210)/deficiency animals ( Fig. 2F ). We performed a complementation test with teg-4(oz210) and a pre-existing deletion allele of tag-203(ok883) Fig. 2 -teg-4(oz210) partially reduces teg-4 activity. Adult hermaphrodites one day past L4 were analyzed using DIC optics. For each image, the distal end of the gonad is on the top left (*), and only one gonad arm for each genotype is shown. Each gonad has been traced with a dashed line. (A) Wild-type gonad arm with oocytes (arrows) in the proximal arm and embryos (arrowheads) in the uterus. (B) teg-4(oz210); glp-1(ar202gf) gonad with no obvious gametogenesis. A tumor of proliferating cells is in the proximal end of the gonad. (C) Actual genotype dpy-5(e61) teg-4(oz210)/qDf16. (D) Actual genotype dpy-5(e61) teg-4(oz210)/ hDf8. (E) Actual genotype dpy-5(e61) teg-4(oz210)/tag-203(ok883). (F) Wild-type (N2) animals in the first larval stage were fed teg-4(RNAi) bacteria and analyzed upon reaching adulthood. All animals displayed a smaller than normal germ line, 60% of which had no obvious gametes, while the rest had some sperm and/or oocytes present (n = 40 animals). Scale bar = 50 lm.
and found that the alleles failed to complement, suggesting that they are allelic (Fig. 2E) . We then sequenced tag-203 using DNA from teg-4(oz210) homozygous animals and found a guanine to adenine nucleotide substitution, which is predicted to cause a glycine to aspartic acid substitution in a highly conserved residue (Fig. 3B ). The narrowing of the critical region of oz210 to a relatively small region, the similarity of the teg-4(oz210)/deficiency and RNAi phenotypes, the failure of the tag-203(ok883) deletion allele to complement teg-4(oz210), and the presence of a missense mutation predicted to substitute a highly conserved amino acid all suggest that teg-4 and tag-203 are the same gene. TEG-4 is homologous to the SAP130 human splicing factor 3b subunit 3 (Das et al., 1999) , Rse1p from Saccharomyces cerevisiae (Chen et al., 1998) , and Prp12p from Schizosaccharomyces pombe. These proteins are part of the U2 snRNP associated complex SF3b, which is essential for pre-mRNA splicing (Caspary et al., 1999; Dziembowski et al., 2004 ).
teg-4. is not a general negative regulator of Notch signaling
The enhancement of glp-1(ar202gf) by teg-4(oz210) could be explained either by teg-4 acting genetically upstream of Notch signaling, functioning as a negative regulator of Notch signaling, or downstream of Notch signaling, possibly in either the gld-1 or gld-2 pathways (Fig. 1C) . In order to determine if teg-4 is a general negative regulator of Notch signaling, we first analyzed its ability to control other cell fate decisions regulated by Notch signaling, such as vulval formation. LIN-12 is the Notch homologue involved in controlling different aspects of vulval formation (Ferguson and Horvitz, 1985; Greenwald et al., 1983) . For example, LIN-12/Notch signaling regulates the AC/VU decision (anchor cell/ventral uterine cell) in vulval formation (Sternberg, 2005) . Z1.ppp and Z4.aaa are roughly equivalent cells that have equal probability to take on the AC or VU fates. Z1.ppp and Z4.aaa interact with each other via the LIN-12/Notch receptor and LAG-2 ligand, culminating in one cell becoming the AC and the other becoming the VU. Increased Notch signaling results in both cells adopting the VU fate and reduced signaling results in both cells adopting the AC fate (Greenwald et al., 1983) . Another Notch regulated cell fate decision in vulval formation involves the adoption of the 1°, 2°or 3°fates by six vulval precursor cells (VPCs). In wild-type animals, one VPC takes on the 1°fate, the two cells on either side of the 1°cell take on the 2°fate, and the remaining cells take on the 3°fate (Sternberg, 2005) . Lateral signaling between the VPCs via the LIN-12/Notch signaling pathway help establish the pattern of 1°and 2°cells. In mutant animals with increased LIN-12/Notch signaling, lateral signaling is increased, resulting in an increase in 2°cells and a multi-vulval (Muv) phenotype. In order to determine if teg-4 interacts with the Notch signaling pathway, we determined if teg-4(oz210) can influence the AC/VU decision and/ or VPC specification in sensitized genetic backgrounds. Since teg-4(oz210) causes over-proliferation in the germ line, and Notch signaling promotes proliferation, if teg-4 interacts with the Notch signaling pathway, we would expect teg-4 to be an inhibitor of Notch signaling; therefore, teg-4(oz210) would increase Notch signaling levels. We found that teg-4(oz210) does not suppress the two AC cell phenotype associated with the weak loss-of-function allele lin-12(ar170) ( Table 4) . teg-4(oz210) also does not enhance the Muv phenotype of the lin-12(n676gf) or lin-12(n379gf) weak gain-of-function alleles (Table 4) . Therefore, teg-4 does not appear to be a general negative regulator of Notch signaling; either teg-4 does not inhibit Notch signaling activity, or this activity is found in the germ line, but not the vulva.
To further address the question of where teg-4 could be functioning in the genetic pathway regulating the prolifera- (A) teg-4(oz210) was mapped to a region of $82 kb on chromosome I using standard three factor and SNP mapping. Dpy and Unc non-tumorous recombinants were isolated from dpy-5(e61) teg-4(oz210)/ HA-8; glp-1(ar202gf) and teg-4(oz210) unc-13(e51)/HA-8; glp-1(ar202gf) animals, respectively. These recombinant animals were then tested for the presence of wild-type (N2) or Hawaiian (HA-8) DNA at various single nucleotide polymorphisms (SNPs), whose relative positions are shown on the top line. The number of recombinants retaining wild-type (N2) DNA relative to the total number of recombinants is shown below each SNP. SNP mapping narrowed the location of teg-4(oz210) to the region between SNPs CE1-171 and hw7381 on cosmids C37A2 and T21G5. The exact location of each SNP on the chromosome is shown above each cosmid name (Wormbase freeze 180; (*) the location of SNP hw7381 can be found in Wormbase 190). A blow-up shows the relative locations of the 18 genes within the critical region. The final blow-up shows the predicted gene model of tag-203 with squares depicting exons and lines depicting introns. The locations of the predicted missense mutation found in teg-4(oz210) animals, and the ok883 deletion allele, are also shown. (B) A small region of the predicted TEG-4 protein is shown compared to SAP130 homologues from other organisms, as aligned using CLUSTALW software (Chenna et al., 2003) . The position of the glycine to aspartic acid substitution predicted to occur due to the nucleotide substitution found in oz210 animals is shown above the alignment. Accession numbers for these proteins are TEG-4 (NP_491953), Homo sapiens (NP_036558), D. melanogaster (NP_728546) and S. pombe (NP_594414). TEG-4 is 60% identical/76% similar, 57% identical/74% similar and 40% identical/60% similar to the Human, Drosophila and S. pombe proteins, respectively. tion vs. meiotic entry decision (Fig. 1C) , we performed double mutant analysis with gld-1 and gld-2 pathway genes. As mentioned previously, genes in the gld-1 and gld-2 pathways function redundantly. If the activity of one of the pathways is eliminated (e.g. gld-1(0) or gld-2(0) single mutants), entry into meiosis occurs relatively normally (Eckmann et al., 2004; Francis et al., 1995; Hansen et al., 2004a; Kadyk and Kimble, 1998) . However, if the activities of both pathways are eliminated (e.g. gld-2(0) gld-1(0) double mutant), the balance between proliferation and meiotic entry is shifted toward proliferation, and a germline tumor forms, similar to the tumor formed in a glp-1(gf) mutant (Berry et al., 1997; Eckmann et al., 2004; Hansen et al., 2004a,b; Kadyk and Kimble, 1998 ). Therefore, we tested if teg-4 functions in one of the two pathways by determining if teg-4(oz210) animals form a germline tumor when the function of a gene in either the gld-1 or gld-2 pathway is also eliminated. We found that teg-4(oz210) forms a synthetic tumor with both gld-1 and gld-2 pathway genes (Table 5) . Specifically, teg-4(oz210) forms a synthetic tumor with the presumed null alleles gld-1(q485), gld-2(q497) and gld-3(q730) ( Table 5 and Fig. 4) . Not all cells within these tumors are proliferative; rather, many cells do show evidence of having entered meiotic prophase. This is similar to other tumors that are due to mutations in the gld-1 and gld-2 pathways (Eckmann et al., 2004; Hansen et al., 2004a,b; MacDonald et al., 2008; Pepper et al., 2003) . Since tumors are formed when either gld-1 or gld-2 pathway genes are mutated in a teg-4(oz210) background, teg-4 is unlikely to function exclusively in one of these two genetic pathways. Surprisingly, teg-4(oz210) is not synthetic tumorous with a presumed null allele of the other gld-1 pathway gene, nos-3. This lack of tumor formation is likely due to nos-3(oz231) not completely eliminating gld-1 pathway activity; gld-2(q497) gld-1(q485) double mutant tumors are more proliferative (have far fewer cells entering meiosis) than gld-2(q497); nos-3(oz231) double mutant tumors (Hansen et al., 2004a,b) . Therefore, teg-4(oz210) must require a significant reduction in gld-1 pathway activity for the formation of a synthetic tumor.
2.7.
Epistasis with glp-1(0)
As mentioned above, a reduction in teg-4 activity does not affect general Notch signaling; however, it is possible that teg-4 inhibits Notch signaling in the germ line. A reduction in teg-4 activity could increase Notch signaling, which could cause a tumor when the activity of the gld-1 or gld-2 pathway is reduced. Indeed, an increase in Notch signaling does cause syn- that observed in wild-type animals. ''Not tumorous'' means that proliferative cells are restricted to the distal end of the gonad and that the size of the proliferative zone is similar to wild-type, although it was slightly larger or smaller for some mutants. ''Tumorous'' animals are those with a large number of proliferative cells (at least as many as normally found in the distal end of the gonad) found in other regions of the gonad. These animals were not completely tumorous in that some cells in the gonad were in meiotic prophase. Animals labeled ''Glp'' have no proliferative cells present in the germ line in late larval or adult stages. All animals labeled tumorous were analyzed by dissecting the gonads and staining with anti-REC-8 and anti-HIM-3 antibodies to determine the extent of over-proliferation (Zetka et al., 1999; Pasierbek et al., 2001; Hansen et al., 2004b) , except for teg-4(oz210) gld-1(q485) animals, which were observed by DIC microscopy. In all cases >20 animals were analyzed with all showing the stated phenotype, unless otherwise noted. b gld-1(q485) hermaphrodites have a tumorous germ line due to a failure of female germ cells to progress through meiotic prophase; this tumor is not due to a disruption in the balance between proliferation and meiotic entry (Francis et al., 1995b) . Therefore, we analyzed the germline phenotype in male animals, which exhibit normal proliferation. c Francis et al., 1995b. d A small percentage of gld-2(q497) animals have over-proliferation in the proximal end of the gonad (Kadyk and Kimble, 1998 ). e Eckmann et al., 2002. f Kraemer et al., 1999. g Austin and Kimble, 1987. h Germline phenotype in males was analyzed. 24/35 males displayed a germline tumor.
i Actual genotype dpy-5(e61) teg-4(oz210); gld-3(q730). j Actual genotype teg-4(oz210) unc-13(e450); nos-3(oz231). k Germline phenotype in males was analyzed. Actual genotype teg-4(oz210) gld-1(q485); unc-32(e189) glp-1(q175). l Actual genotype gld-2(q497) teg-4(oz210); unc-32(e189) glp-1(q175). m Actual genotype dpy-5(e61) teg-4(oz210); gld-3(q730); unc-32 (e189) glp-1(q175).
thetic over-proliferation when the activity of a gld-1 or gld-2 pathway gene is reduced (Hansen et al., 2004a) . To test if the tumors formed in gld-2(q497) teg-4(oz210), teg-4(oz210) gld-1(q485) and teg-4(oz210); gld-3(q730) animals are due to an increase in Notch signaling, we eliminated Notch signaling in the germ line with the glp-1(q175null) allele in each of the double mutants. The results of these three triple mutant strains provided conflicting results; gld-2(q497) teg-4(oz210); glp-1(q175) and teg-4(oz210) gld-1(q485); glp-1(q175) animals have an under-proliferative (Glp-germ line proliferation abnormal) phenotype, whereas the teg-4(oz210); gld-3(q730); glp-1(q175) animals have a tumorous germ line (Table 5) . A superficial interpretation of these results is that the gld-2(q497) teg-4(oz210) and teg-4(oz210) gld-1(q485) synthetic tumors require Notch signaling for formation; therefore, teg-4 likely functions upstream of Notch signaling as a negative regulator. But the teg-4(oz210); gld-3(q730) tumor does not require Notch signaling; therefore, teg-4 likely functions downstream of Notch signaling. These conflicting results can be reconciled if one accounts for teg-4(oz210) not being a null allele. teg-4 could function downstream of Notch signaling, and when Notch signaling is removed in gld-2(q497) teg-4(oz210) and teg-4(oz210) gld-1(q485) animals though the use of the glp-1(q175) null allele, the repression of teg-4 activity by Notch signaling would be relieved, thereby causing residual teg-4 activity to be increased, causing the cells to enter into meiosis prematurely. Therefore, since teg-4(oz210) is not a null allele, the Glp phenotype in gld-2(q497) teg-4(oz210); glp-1(q175) and teg-4(oz210) gld-1(q485); glp-1(q175) animals is inconclusive in determining the requirement for Notch signaling in tumor formation. However, the tumorous phenotype in teg-4(oz210); gld-3(q730); glp-1(q175) animals does show that a tumor can be formed in the absence of Notch signaling. Therefore, even though teg-4(oz210) is not a null allele, the fact that a tumor can form in the absence of Notch signaling shows that the contribution of teg-4(oz210) to over-proliferation cannot solely be due to a release of Notch signaling repression; rather, teg-4 likely functions either downstream or parallel to Notch signaling in the genetic pathway regulating the balance between proliferation and meiotic entry.
Discussion
teg-4 encodes a C. elegans homologue of the human SAP130 and Saccharomyces cerevisiae Rse1p splicing factors (Chen et al., 1998; Das et al., 1999) . SAP130 is a component of the SF3b subunit of the U2 small nucleotide ribonucleoprotein (snRNP) complex (Das et al., 1999) . The U2 snRNP associates with the branch point region of the pre-mRNA in the formation of the spliceosome ( -teg-4(oz210) forms a germline tumor with gld-2(q497). Gonad arms were dissected from adult hermaphrodites grown at 20°one day past the fourth larval stage. The fixed gonad arms were stained with DAPI (A,C,E and G), which shows nuclear morphology (blue), anti-REC-8 antibodies, which mark mitotic cells (green) and anti-HIM-3 antibodies (red), which mark meiotic cells (B,D,F and H). The distal end of each gonad is to the left. Pictures were taken using the Apotome (Zeiss) module to remove background florescence. Scale bar = 50 lm. function of SAP130 is essential for viability in both budding and fission yeast (Caspary et al., 1999; Habara et al., 2001) , suggesting that it provides an essential function in splicing. Here we have shown that a mutation that partially reduces activity in the C. elegans homologue of SAP130, TEG-4, causes a disruption in the balance between proliferation and differentiation in the C. elegans germ line, as well as a disruption in the switch from spermatogenesis to oogenesis in the hermaphrodite. Additionally, RNAi against teg-4, which presumably reduces teg-4 activity to a greater extent than teg-4(oz210), causes embryonic arrest, suggesting that TEG-4 is also essential for viability.
TEG-4's role in the proliferation vs. meiotic entry decision
Perhaps the simplest explanation for the effect teg-4(oz210) has on the proliferation vs. differentiation decision, as well as in germline sex determination, is that a reduction in TEG-4 activity lowers splicing efficiency, causing a key regulator(s) to be expressed at lower levels due to improper or less efficient splicing. Supporting this model is the isolation of mutations in other splicing factors that cause similar phenotypes to what we observed with teg-4(oz210). A reduction in DDX-23 activity, which is a homolog of the yeast splicing factor PRP28, results in animals that are Mog and have a smaller germ line (Konishi et al., 2008) . A reduction in the activities of MOG-1, MOG-4 or MOG-5, which are homologues of DEAH-box containing splicing factors PRP16, PRP2 and PRP22, respectively Kimble, 1999, 2000) , results in a Mog phenotype . Additionally, when gld-3 activity is reduced by RNAi in mog-1, mog-4 or mog-5 mutant animals, a significant percentage of animals form a germline tumor (Belfiore et al., 2004) . Finally, loss of cyn-4/mog-6 activity, which codes for a cyclophlin, causes a Mog phenotype, as well as germline over-proliferation in a gld-3(0) mutant background (Belfiore et al., 2004; . Cyclophilins have many functions, including involvement in pre-mRNA splicing (Horowitz et al., 1997 (Horowitz et al., , 2002 Ingelfinger et al., 2003; Reidt et al., 2003; Teigelkamp et al., 1998) . Since a number of splicing factor homologues show the same general Mog phenotype, as well as defects in germline proliferation, it seems likely that a reduction in splicing efficiency is the cause of the phenotypes. However, previous work has found no evidence for a general splicing defect in mog-1 or mog-6 mutants (Belfiore et al., 2004; Puoti and Kimble, 1999) . Through both northern analysis and RT-PCR, a number of candidate genes (e.g. fem-3, fbf, nos-3, gld-3 and lag-1) were tested for defects in splicing in mog-1 and/or mog-6 mutants (Belfiore et al., 2004; Puoti and Kimble, 1999) . Splicing defects were not observed in any of these genes in mog-1 or mog-6 mutant animals, even though the mog alleles used are presumed null alleles. It is possible that these mutations that cause a Mog and/or over-proliferation phenotype only cause a small reduction in splicing efficiency, and that attempts to detect splicing defects in these mutants were not sensitive enough to detect a small degree of mis-splicing. It is also possible that splicing efficiency is reduced in these mutants to a level that only certain genes that are more sensitive to changes in splicing efficiency are mis-spliced. Certain genes being more sensitive to changes in splicing efficiency has been observed in fission yeast (Habara et al., 2001) . Therefore, perhaps the gene(s) responsible for the Mog and over-proliferation phenotypes in teg-4(oz210) and other splicing factor mutants have not yet been tested for mis-splicing. It is likely that all mutations in splicing factors that cause a Mog or germline overproliferation phenotype only partially reduce splicing efficiency. A complete disruption of splicing would presumably cause a complete breakdown of the developmental program, as is seen in teg-4(RNAi) animals. Only when the activity of a core-splicing factor is partially reduced (e.g. teg-4(oz210)), or when the activity of a non-essential splicing factor is eliminated (e.g. mog-1(null)), is a germline phenotype able to be produced. Therefore, a partial reduction in splicing activity may be difficult to detect; either because the affected target has not yet been tested, or because the level of mis-splicing, although resulting in a biological consequence, is difficult to detect molecularly.
While a reduction in splicing efficiency is a plausible model to explain the observed Mog and proliferation phenotypes, it is also possible that these splicing factors have roles in processes other than splicing, and that it is a disruption in these non-splicing processes that is the cause of the phenotypes. Indeed, it has recently been reported that a reduction in the activities of certain splicing factors in fission yeast, including the homologue of TEG-4, have non-splicing functions (Bayne et al., 2008) . When the activities of certain splicing factors were reduced, the generation of siRNAs was impaired, which reduced centromeric heterochromatin integrity. It was demonstrated that the defect in siRNA generation, when splicing factor activity was reduced, is independent of splicing. Therefore, splicing factors may have a direct role in RNAi. Additionally, C. elegans splicing factors were identified in a screen for genetic components necessary for RNAi, further supporting a role for splicing factors in RNAi (Kim et al., 2005) . Therefore, a reduction of splicing factor activity may affect processes other than, or in addition to, splicing. The sex determination and proliferation defects associated with teg-4(oz210), and mutations in other splicing factors, may be due to a reduction in these non-splicing functions.
Splicing factors and tumor formation
We have shown that a reduction in the activity of a conserved splicing factor, SAP130/TEG-4, promotes tumor formation in a sensitized genetic background. Changes in the splicing, particularly alternative splicing, of certain genes has been implicated in many cancers and tumor formation in humans (Srebrow and Kornblihtt, 2006; Venables, 2006; Wang and Cooper, 2007) . Recent bioinformatic analysis has suggested that at least some of these disruptions in normal splicing, which are correlated with many cancers, may be due to changes in expression of splicing factors (Kim et al., 2008; Ritchie et al., 2008) . Many cancers display an up-regulation of certain splicing factors (Grosso et al., 2008) ; however, other splicing factors are down-regulated in certain cancers (Ding et al., 2002; Oh et al., 2006; Pacheco et al., 2006; Roychoudhury and Chaudhuri, 2007; Shitashige et al., 2007a,b) . Additionally, the cdc5+ gene in Schizosaccharomyces pombe en-codes a conserved splicing factor that is necessary for the G2/ M transition in the cell cycle (Ajuh et al., 2000; Burns et al., 1999; McDonald et al., 1999; Nasmyth and Nurse, 1981; Ohi et al., 1994) . Therefore, a decrease in the cdc5 splicing factor activity decreases proliferation (Nasmyth and Nurse, 1981) . In C. elegans, another cell cycle regulator, CDC-25.1, is necessary for proliferation and maintenance of the germ line (Ashcroft and Golden, 2002) . Reduction in the functions of a subset of splicing factors, including teg-4, is able to suppress intestinal hyperplasia caused by a cdc-25.1 gain-of-function allele, presumably by decreasing proper splicing of cdc-25 (Hebeisen et al., 2008) . We have shown that a decrease in TEG-4 activity, in an otherwise wild-type background, results in decreased germline proliferation. Therefore, this reduction in proliferation could be due, at least partially, to a decrease in CDC-25.1 activity. However, we also demonstrated that a reduction in TEG-4 activity results in increased germline proliferation in a genetically sensitized background. Presumably numerous targets are affected when splicing efficiency is decreased; some of the targets may promote proliferation and others may inhibit proliferation. The degree of the decrease in splicing efficiency, as well as the genetic background, may determine if under-proliferation or over-proliferation results. A reduction in SAP130/TEG-4 activity has been proposed as the mechanism by which the anti-tumor natural product pladienolide functions (Kotake et al., 2007) . Additionally, the anticancer compounds FR901464 and spliceostatin A are thought to function through the inhibition of the SAP130 containing complex, SF3b. Therefore, a reduction in SAP130/ TEG-4 activity in mammals is thought to inhibit proliferation, similar to the decrease in proliferation observed in our teg-4(oz210) single mutant. Perhaps a change in genetic background could, like in teg-4(oz210); glp-1(ar202gf) animals, cause these anti-tumor compounds to increase proliferation. Certainly, a complete understanding of how changes in splicing factor expression levels affect proliferation, either increasing or decreasing proliferation, will require identification of the target RNAs.
4.
Experimental procedures
General methods and strains
Maintaining and manipulation of C. elegans was performed as described in (Brenner, 1974) . All strains were derived from wild-type strain C. elegans var. Bristol (N2) unless otherwise indicated. Experiments were performed at 20°C unless otherwise indicated. The following mutations were used in this study -LGI: dpy-5(e61), gld-2(q497), teg-4(oz210), tag-203(ok883), unc-13(e51), unc-13(e450), unc-13(e1091), gld-1(q485); LGII: gld-3(q730), nos-3(oz231); LGIII: unc-32(e189), glp-1(q175), glp-1(ar202gf), lin-12(n676gf), lin-12(n379gf), and lin-12(ar170).
SNP mapping
Standard three factor mapping was used to narrow the location of the teg-4(oz210) mutation in between dpy-5 and unc-13 on chromosome I. To further narrow the critical region we performed single nucleotide polymorphism (SNP) mapping (Jakubowski and Kornfeld, 1999) . From dpy-5(e61) teg-4(oz210)/HA-8; glp-1(ar202gf) and teg-4(oz210) unc-13(e51)/HA-8; glp-1(ar202gf) animals we isolated 56 Dpy non-tumorous and 25 Unc non-tumorous recombinants respectively (Fig. 3A) . Progeny of the recombinant strains that were homozygous for the recombinant chromosome were tested for the presence of Hawaiian (HA-8) or Bristol (N2) DNA at various SNP locations (Fig. 3A) (Wicks et al., 2001) . One Dpy nontumorous and five Unc non-tumorous recombinants narrowed the location of teg-4(oz210) to the region between SNPs CE1-171 and hw7381, which is a region of $83 kb.
RNA interference
RNAi plates (standard NGM plates containing 25 lg/mL carbenicillin and 0.2% Beta-lactose) were seeded with an overnight culture of K02F2.3-pL4440 HT115(DE3) bacteria, obtained from the Ahringer RNAi library (Fraser et al., 2000) , or gfp-pL4440 HT115(DE3) bacteria (control) (Timmons and Fire, 1998) , and grown for two days to establish the bacterial lawn. Wild-type (N2) L4 or young adult hermaphrodites were placed on the RNAi plates and left overnight at 22°. The adult worms were then transferred to a second RNAi plate and further incubated overnight at 22°before being removed from the plate. After two full days after removal of the adult worm, the number of unhatched eggs, larval and adult worms were scored from both the first and second plates. Worms were monitored for an additional three days to determine the stage of arrest. To obtain worms with lower exposure to RNAi, and therefore allow for worms to reach adulthood and display a germline phenotype, L1 animals were exposed to RNAi. Arrested wild-type L1 animals were placed on RNAi plates and incubated at 22°for 3-5 days. The adult worms were then scored under DIC optics on a Zeiss Imager Z1 for their germline phenotype.
Gonad dissections and staining
Dissection of gonads and subsequent antibody staining was performed as previously described (Jones et al., 1996) . Dissected gonads were fixed using 3% formaldehyde, 0.1 M KPO4 (pH 7.2), for five to 60 min. The gonads were then post-fixed in À20°100% methanol for >10 min. Anti-REC-8 antibodies (Pasierbek et al., 2001) , were used at a 1:100 dilution and anti-HIM-3 antibodies (Zetka et al., 1999) , were used at a 1:500 dilution. Images, both DIC and fluorescent, were taken from a Zeiss Imager Z1 microscope equipped with an Axiocam MRM digital camera. Acquisition of fluorescent images utilized the Apotome module (Zeiss) to minimize background fluorescence.
nematode strains in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH Na- 
